The relationship between anti-thyroid peroxidase serum levels with prognostic factors in breast cancer and two- year survival of patients
محل انتشار: سومین سمپوزیوم بین المللی سرطان نسترن
سال انتشار: 1396
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 410
نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
این مقاله در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
NASTARANCANSER03_067
تاریخ نمایه سازی: 7 اسفند 1396
چکیده مقاله:
Anti-Thyroid peroxidase (Anti-TPO) is an autoantibody secreted by the thyroid gland, which is naturally measurable in small quantities in serum. According to the studies carried out, this autoantibody may be used as a marker of prognosis in breast cancer. Of This study the aims was to evaluate the relationship between Anti-TPO serum levels with prognostic factors in breast cancer and two-year survival ofpatients in Qaem hospital Mashhad Iran. To implement this project, 50 patients suffering from breast cancer who referred to Qaem Hospital in Mashhad during the years 2009-2010 were selected.Metastatic patients were excluded from the study and informed consent was obtained from all the patients. The serum levels of Anti-TPO was measured by Elisa Kit (monobind cristal company) Therelationship between the levels of Anti-TPO autoantibody with Estrogen Receptor(ER) , Progesterone Receptor(PR), Human Epidermal Cell Growth Factor Receptor 2 (HER-2), tumor grade and stage wasdetermined in addition to the relationship between these factors with two-year survival. Data was analyzed using SPSS software version 20 and P-value of less than 0.05 was considered significant. Themean serum level of Anti-TPO in patients was equal to 21.58 IU/mL which is within the normal range (less than 40 IU/mL). No significant relationship was found between Anti-TPO serum levels, tumorgrade (p-value=0/474), disease stage (p-value=0/507), ER (p-value=0/1), PR (p-value=1/000), HER-2 (p-value=1/000), two-year disease-free survival (p-value=0/379) and life status (p-value=0/351). Mostpatients were in stage 3a and low patients are in stage 4. Most patients are in grade 2 and least patients were in grade 1. According to the results obtained in this study, Anti-TPO serum levels had nosignificant relationship with any of the prognostic factors in breast cancer and two-year survival of patients including patients with and without the relapse of illness.
کلیدواژه ها:
Breast Cancer ، Cancer Symptoms ، Cancer Diagnosis ، Cancer Prevention ، Cancer Treatment and Management
نویسندگان
Hossein Javid
Department Of Clinical Biochemistry ,Faculty Of Medicine,Mashhad University Of Medical Sciences,Mashhad,Iran
Mohammad Soukhtanloo
Department Of Clinical Biochemistry ,Faculty Of Medicine,Mashhad University Of Medical Sciences,Mashhad,Iran